The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 13, 2018

Filed:

Sep. 10, 2015
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

David S. Bradford, Sausalito, CA (US);

Jeffrey C. Lotz, San Mateo, CA (US);

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 6/00 (2006.01); A61K 49/00 (2006.01); A61B 5/00 (2006.01); A61N 7/02 (2006.01); A61B 18/14 (2006.01); A61K 51/10 (2006.01); A61M 5/00 (2006.01); A61M 5/172 (2006.01); A61B 18/00 (2006.01);
U.S. Cl.
CPC ...
A61B 6/506 (2013.01); A61B 5/4041 (2013.01); A61B 18/14 (2013.01); A61K 49/0002 (2013.01); A61K 51/1096 (2013.01); A61M 5/007 (2013.01); A61M 5/1723 (2013.01); A61N 7/02 (2013.01); A61B 5/4824 (2013.01); A61B 2018/00339 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00642 (2013.01); A61M 2230/005 (2013.01);
Abstract

Pain factors are labeled with targeted agents or markers delivered into the body. The labeled pain factors are imaged with appropriate imaging tools in a manner allowing selective identification and localization of areas of pain source or transmission. The labeled pain factors allow spatial differentiation in the imaging sufficient to specify the location of the pain so as to drive therapeutic decisions and techniques in order to treat the pain. Pain factors labeled and imaged in this manner may include one or more of nerve factors, blood vessel factors, cellular factors, and inflammation factors. Labeled markers may include for example radioactive materials (e.g. tritiated or iodinated molecules) or other materials such as metal (e.g. gold) nanoparticles. Intermediary binding materials may be used, such as for example bi-specific antibodies.


Find Patent Forward Citations

Loading…